Biotricity (OTCMKTS:BTCY – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.05) EPS for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.06, Zacks reports. The company had revenue of $3.62 million for the quarter, compared to the consensus estimate of $3.30 million.
Biotricity Trading Down 2.4 %
Biotricity stock opened at $0.64 on Friday. Biotricity has a 1 year low of $0.19 and a 1 year high of $1.67. The company has a market cap of $15.81 million, a PE ratio of -0.38 and a beta of 1.18. The company’s 50-day moving average is $0.37 and its two-hundred day moving average is $0.36.
About Biotricity
Recommended Stories
- Five stocks we like better than Biotricity
- What Are the U.K. Market Holidays? How to Invest and Trade
- Garmin’s Growth Signals Wearables Surge: Stocks to Watch
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- 3 Precious Metals ETFs Gaining Big as Gold Nears New Highs
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- These 3 Defensive Retail Stocks Are Outpacing the Market
Receive News & Ratings for Biotricity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotricity and related companies with MarketBeat.com's FREE daily email newsletter.
